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Abstract
Humane use of preclinical large animal cancer models plays a critical role in understanding cancer biology and developing
therapeutic treatments. Among the large animal candidates, goats have great potentials as sustainable sources for large
animal cancer model development. Goats are easier to handle and cheaper to raise. The genome of the goats has been
sequenced recently. It has been known that goats develop skin, adrenal cortex, breast and other types of cancers.
Technically, goats are subject to somatic cell nuclear transfer more efficiently and exhibit better viability through the cloning
process. Towards the development of a goat cancer model, we created a transgenic goat fetal fibroblast (GFF) cell as the
donor cell for SCNT. Human mutated K-ras (hK-rasG12D) was chosen as the transgene, as it is present in 20% of cancers. Both
hK-rasG12D and a herpes simplex viral thymidine kinase (HSV1-tk) reporter genes, flanked by a pair of LoxP sites, were
knocked in the GFF endogenous K-ras locus through homologous recombination. Following Cre-mediated activation (with a
95% activation efficiency), hK-rasG12D and HSV1-tk were expressed in the transgenic GFF cells, evidently through the
presence of corresponding mRNAs, and confirmed by HSV1-tk protein function assay. The hK-rasG12D expressing GFF cells
exhibited enhanced proliferation rates and an anchorage-independent growth behavior. They were able to initiate tumor
growth in athymic nude mice. In conclusion, after activating hK-rasG12D gene expression, hK-rasG12D transgenic GFF cells
were transformed into tumorgenesis cells. Transgenic goats via SCNT using the above-motioned cells as the donor cells
have been established.
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other types of cancers [1–4]; 2) goat genome has been sequenced
recently [5]; and 3) comparing to pigs or other large animals, goats
are more robust to the cloning process, easier to handle and less
expensive to raise, which makes them sustainable as an animal
model source.
K-ras, a 21 kDa membrane-bound GTPase, which regulates
cell growth, proliferation, and differentiation, is a key player in the
development and in carcinogenic processes and tumor maintenance [6–8]. K-ras mutations can prevent the enzyme from
hydrolyzing GTP, resulting in an up-regulation of downstream
signaling activity, which leads to uncontrolled proliferation,
resistance to apoptosis, metastasis, and ultimately cancer [9,10].
It has been well documented that K-ras genes are mutated in
,20% human cancers, ranging from pancreatic cancer, lung
cancer, and breast cancer, among others [11]. Accordingly, we
chose mutated human K-ras as the transgene to create a mutated
human K-ras transgenic goat. The transformation of the mutated
human K-ras transgenic goat to a K-ras transgenic goat cancer
model is inspired by the reports that expression of K-ras in
transgenic mice induces tumors [12–14]. We hypothesized that the
expression of mutated K-ras gene should also result in tumor

Introduction
Mice are the most commonly used animal model due to the vast
array of reagents and gene manipulation strategies currently
available for this species. However, the small size of the mouse and
its anatomical structures present problematic issues when measuring the pathophysiologic parameters of cancer or other diseases.
This is especially evident when comparing the vastly different
physiologic values between mice and humans. The use of large
animals for modeling cancer would overcome these issues. Large
animals (dogs, sheep, goats, pigs, and nonhuman primates) have
large organs and blood volumes that allow repeated blood
sampling, which can provide critical data for kinetic pharmacologic studies, a mission impossible in small animal studies. The
results obtained from large animal experiments can be applied
easily to human protocols. Given the state-of-the-art vivarium
infrastructure for large animals and strong efforts in large animal
cloning at Utah State University (USU), we are carrying out an
initiative to develop large animal cancer models using transgenic
goats. The choice of goats for cancer model development is
motivated by 1) goats develop skin, adrenal cortex, breast and
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Integrated BioSystems (CIB) at Utah State University. Electroporation devices of AmaxaTM 4D-nucleofector (Lonza) and P3
Primary Cell 4D-NucleofectorTM X Kit (Lonza) were used in this
study. Goat genomic DNA was extracted using PureLink
Genocmic kit (Invitrogen Cat: K1820).

growth in goats. In an unlikely event that the expression of
mutated K-ras would not lead to the tumor phenotypes in goats,
the availability of a transgenic goat with inducible expression of
oncogenic human K-ras would still be a great asset for studying the
mechanism of K-ras related bio-processes and for screening and
testing potential drugs related to K-ras.
More specifically, we aimed at developing a K-ras transgenic
goat model for lung cancer. Lung cancer is the most lethal cancer,
accounting for almost one third of total cancer mortality. A high
percentage of lung cancers express K-ras gene with mutations in
codon 9–13 [16]. The site of K-ras mutation is confined almost
entirely to codon 12, and the spectrum of mutations is limited such
that valine, arginine, aspartic acid, or cysteine is substituted for the
normally encoded glycine [17]. This region in K-ras is highly
conserved and is identical among mouse, goat, and human.
Our approach for developing a K-ras transgenic large animal
model uses somatic cell nuclear transfer (SCNT) method to
produce genetically modified goats expressing inducible (through
LoxP/Cre recombination) human mutated K-ras oncogene (hKrasG12D thereafter) and a herpes simplex viral thymidine kinase
HSV1-tk gene, a well-established reporter gene. HSV1-tk,
although in the presence of goat endogenous tk, can be specifically
detected by isotope labeled thymidine analog using positron
emission tomography (PET) imaging; therefore, the expression of
the hK-rasG12D gene upon Cre-mediated activation can also be
detected [18,19]. The incorporation of a reporter gene to the hKras gene has profound effect on producing a transgenic large
animal with a latent transgenic disease-caused gene(s) embedded
in its genome. Large animals have a much longer lifespan, and the
effect of activated transgene(s), as well as the appearance of disease
phenotype, could take a long time to manifest. Capabilities of
knowing when and where the transgene product(s) is expressed, as
well as whether there are any pre-symptom signatures due to the
function of transgene product(s) will shed light on the developmental nature (disease initiation) of model development. The
reporter gene will enable imaging the effectiveness of hK-ras
activation and hK-ras location/expression level upon activation in
transgenic goats by PET.
In this report, we focus on in vitro studies related to the
development of a hK-ras transgenic goat, including the vector
construction, development of transgenic cells, in vitro Cre-mediated
activation of hK-rasG12D and HSV1-tk gene expression, and
phenotyping of the corresponding activated cells. Guided through
the genome sequences of goat [5], we have knocked in both hKrasG12D and HSV1-tk gene under the same upstream promoter in
the goat endogenous K-ras locus through homologous recombination. Transgenic cells were obtained, and the Cre-mediated
activation of hK-rasG12D stimulated oncogenic transformation in
goat fetal fibroblast (GFF) cells. To the best of our knowledge, this
study is the first to report the transformation of goat fibroblast to
tumor genesis under the influence human mutated K-ras gene.

Construction of targeting vector: pKO2.1-LSL-hK-rasG12DIRES-HSV1-tk
Goat genomic DNA was extracted from GFF. The DNA
fragments used as homology arms were a 2 kb goat DNA fragment
derived from the 400 bp upstream of K-ras exon 1 and a 7 kb
fragment from the downstream of K-ras exon 1. The cDNA of
human K-rasG12D was amplified from pcDNA3-krasG12D (a gift of
Dr. Patrizio Castagnola, National Cancer Research Center,
Genova, Italy) and then subcloned into pLOX-gfp-iresTK
(Addgene plasmid 12243). LSL (LoxP-Stop-LxoP) fragment was
amplified from PGKneotpAlox2 (Addgene plasmid 13444). The 7kb of the long homology arm was first inserted into pKO2.1
(Addgene plasmid 22674). Next, in-fusion cloning procedure was
performed to insert 3 directional cloning PCR amplicons (short
homology arm, LSL fragment and hK-rasG12D-IRES-HSV1-tk)
into linearized pKO2.1 in a single reaction. The correct
recombinant colonies were screened by colony PCR and then
verified by the digestion analysis of restriction endonuclease. The
junction sequence of targeting vector: pKO2.1-LSL-hK-rasG12DIRES-HSV1-tk was confirmed by sequencing.

Transfection and detection of targeted cell clones
The primary goat fetal fibroblast cells were isolated from 40-d
goat fetus as previously described [20] and then were used for the
transfection at passage 2 or 3. The linearized targeting vector:
pKO2.1-LSL-hK-rasG12D-IRES-HSV1-tk/AgeI was electroporated into GFF. Fibroblast colonies resistant to neomycin were
expanded and then genotyped by PCR to detect the presence of
the transgene and homologous recombination events.

Removal of stop cassette by Cre
Removal of the Stop element from the LSL-hK-rasG12D-IRESHSV1-tk allele was achieved by the use of Adenovirus-Cre
(University of Iowa, Gene Transfer Vector Core) and then verified
by PCR.

MTT assay
Cells were seeded in 96-well plate and the evaluation of cell
growth using the MTT assay every other days.

Ganciclovir Sensitivity Assay
Cells were seeded in 96-well plates (2000 cells/well) and were
grown for 24 h. The cell culture medium was replaced daily with
ganciclovir-containing medium (Biotang Inc.) at different ganciclovir concentrations. MTT assay was used to measure cell
viability 5 days later.

Methods
Reagents

Clonogenic Assay

Restriction enzymes (FastDigest Xho I, HindIII, AfIII, BglII,
AgeI, NotI and BamHI) were purchased from Thermo Fisher
Scientific Inc. Taq DNA polymerase was obtained from TaKaRa
(Cat: KA4301BA). High-fidelity DNA polymerase was from BioRad (Cat: 172-5330) and the In-Fusion HD Cloning Kit was
acquired from Clontech (Cat: 639645). The primers used in this
study were designed according to the corresponding genes listed
(See Table S1 in File S1) and synthesized by Integrated DNA
Technologies Inc. DNA sequencing was performed by Center for

Five hundred cells were seeded into each well of 6-well plate in
duplicate, and colonies were stained 7–10 days later with 0.2%
crystal violet in 80% methanol.
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Anchorage-Independent Growth Assay
For analysis of anchorage-independent growth, cells were
trypsinized and 10,000 cells per well of 6-well plate were seeded
in medium containing 1.6% Methyl cellulose (Sigma, M0512) with
10% fetal calf serum and plated over a layer of 0.9% agar-coated
2
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inhibited by a transcriptional termination sequence (LoxP-StopLoxP, LSL). Both hK-rasG12D and HSV1-tk were expressed under
the control of goat K-ras promoter and activated by transfection of
Cre gene following the deletion of LoxP-neomycin-stop-LoxP
cassette. Figure 1B illustrates a schematic outline for the
construction of targeting vector pKO2.1-LSL-hK-rasG12D-IRESHSV1-tk.
Details of the vector construction are provided in the
supplementary material (See Figure S1–S5 in File S1). In brief,
to generate the targeting construct of pKO2.1-LSL-hK-rasG12DIRES-HSV1-tk, cloning and long-rang PCR were used to amplify
a large genomic region spanning the exons. In-fusion PCR was
used to ligate 3 inserted fragments into the targeting vector in a
one-step reaction. The essential elements of targeting vector,
including the transcriptional termination LSL, hK-rasG12D-IRESHSV1-tk and all the junction of ligation, were sequenced, and the
results showed correct sequences with no mutations or reading
frame shift. Subsequently, the knock-in vector was linearized and
electroporated into GFF cells. Fibroblast colonies resistant to
neomycin (600 mg/ml) were expanded and 56 neo-resistant
colonies were obtained. To screen for homologous recombination
by PCR, three pairs of primers were designed and used to identify
the targeted locus (See Figure S6 in File S1). PCR-based screening
revealed that 2 out of 56 analyzed GFF colonies contained correct
knock-in targeting gene (Figure 2). Two correct targeting cell lines
(No. 1 and No. 2), in which the homologous recombination event
occurred, were established.

six-well plates. Standard medium (1 mL) was added to the top of
the gelled matrix and colonies were grown for 21 days. After 21
days in culture, colonies were counted in five random threedimensional fields per well and photographed.

RT-PCR and restriction fragment length polymorphism
analysis
Total RNA was extracted from cells using TRIzolH (Invitrogen).
cDNA was synthesized using 2 mg of total RNA with the
SuperScript II First-Strand Synthesis using oligo (dT) primer
System (Invitrogen). Aliquots of the reaction mixture were used
for the subsequent PCR amplification. The primer of HSV1-tk:
59- CAGCAAGAAGCCACGGAAGT-39 (sense) and 59- GGCCCGAAACAGGGTAAATAA-39 (antisense). To detect transcripts
of mutant KRAS, PCR–restriction fragment length polymorphism
(RFLP) method was done as described [21]. The primer sequences
for K-ras amplification were 59-GACTGAATATAAACTTGTGGTAGTTGGACCT-39 (sense) and 59-TCCTCTTGACCTGCTGTGTCG-39 (antisense). The sense primer was designed
to introduce a base substitution that created a BstNI recognition
site for the WT codon 12 (GGT), but not for the codon 12 with the
K-ras mutation. PCR products (15 mL) were digested with 30 units
of BstNI (New England Biolabs) at 60uC for 3 hours, and were run
on 3% agarose gels stained with ethidium bromide.

Telomerase assays
Telomerase assay was measured with a telomerase ELISA kit
(Roche) according the manufacturer’s instructions.

In vivo xenograft growth and
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Activating hK-ras expression in LSL-hK-rasG12D-IRESHSV1-tk transgenic GFF by Cre-LoxP recombination

F-FDG PET imaging

The activation of hK-rasG12D expression was carried out by
infecting the cells with high doses of Adenovirus-Cre-GFP to
remove the transcription termination cassette LSL. The Cre
recombinase caused the excision of the transcriptional Stop
element; thus, resulting in hK-rasG12D expression.
Forty-eight hours after the infection of LSL-hK-rasG12D-IRESHSV1-tk GFF cells with recombinant adenovirus encoding Cre
recombinase, the fluorescence of GFP positive cells could be
observed under the fluorescence microscope (Figure 3A). By
comparing both bright field and florescence images, greater than
95% infected efficiency was achieved. The infected cells were
cultured continuously for 4 weeks until the dominant colonies were
appeared, which was named as Lox-hK-rasG12D-IRES-HSV1-tk
GFF cells.
The removal of the stop element and neomycin gene after
infection was confirmed by PCR using genomic DNA extracted
from GFF cells. PCR primers are illustrated (see Figure S7 in File
S1). Only 279 bp fragment was amplified in wild type GFF cells
and both 279 bp and 2.5 kb fragments were amplified in LSL-hKrasG12D-IRES-HSV1-TK GFF cells. Only DNA prepared from
the Lox-hK-rasG12D-IRES-HSV1-TK GFF cells gave a product,
in which the molecule weight was 40 bases larger than that from
the wild-type allele generated from the hK-rasG12D allele
containing a single loxP site (Figure 3B). The co-existence of
2.5 kb fragment band could be due to the incomplete excision by
Cre recombinase.
Since the goat endogenous K-ras locus was targeted in the LSLhK-rasG12D-IRES-HSV1-tk GFF cells, endogenous levels of hKrasG12D and HSV1-tk proteins should be expressed after the
removal of the Stop element. Figure 3C is the result of
examination of HSV1-tk mRNA by RT-PCR. The result showed
that the HSV1-tk was expressed in Lox-hK-rasG12D-IRES-HSV1tk GFF cells as well as in the LSL-hK-rasG12D-IRES-HSV1-tk
GFF cells infected with Adenovirus-Cre-GFP for 48 h (Figure 3C).

The protocols that involved laboratory animals were performed
in accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of National Institutes of
Health and were approved by the Institutional Animal Care and
Use Committee of Utah State University (IACUC #: 2118). All
surgery was performed under isoflurane anesthesia, and all efforts
were made to minimize suffering.
In vivo tumor growth was examined by injecting cells into six
week-old female Nu/J (JAX) mice. A total 56106 cells were
injected into nude mice subcutaneously. Tumor sizes were
followed after 2 weeks and were measured for 11 weeks.
18
F-FDG was purchased from the Huntsman Cancer in Utah
University, and reconstituted with sterile saline. The mice were
fasted for 12 h before 18F-FDG injection. The animals were
administered 200 mCi 18F-FDG via tail vein injection under
isoflurane anesthesia. Animals remained conscious and were
allowed free access to water during a 2 h uptake period. The
mice were anesthetized immediately before scanning and were
imaged in the prone position for 20 min. PET scans and image
reconstruction were performed using a panel PET scanner
developed by University of Chicago.

Results
Construction of targeting vector and generation of
transgenic cells
Figure 1A depicted the overall strategy for knock-in of hKrasG12D oncogene and HSV1-tk reporter gene in goat fibroblast
cells and the corresponding conditional activation. Both genes
were introduced to the exon 1 locus of goat endogenous K-ras
gene. The hK-rasG12D was transcribed together with the HSV1-tk
due to their linkage through the internal ribosomal entry site
(IRES). The transcription of hK-rasG12D and HSV1-tk genes was
PLOS ONE | www.plosone.org
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Figure 1. Schematic representation of the conditional hK-RasG12D construct. A, Targeting strategy of knock-in of the hK-rasG12D to goat Kras exon 1 locus and its activation by Cre; B, Schematic outline of the cloning strategy for the construction of targeting vector: pKO2.1-LSL-hK-rasG12DIRES-HSV1-tk.
doi:10.1371/journal.pone.0090059.g001

It thus proved that the induced hK-ras allele was efficiently
recombined and expressed.
The function of the HSV1-tk transgene in activated Lox-hKrasG12D-IRES-HSV1-tk GFFs was determined by inhibition of cell
proliferation when the cells were incubated with Ganciclovir
(GCV), a specific substrate of HSV1-tk. Three groups of GFF cells
were treated with GCV at increasing concentrations (from 1 to
100 mg/ml), followed by incubation for 5 days. The cytotoxicity of
the cells was assayed in triplicate for each concentration using
MTT assays. As shown in Figure 3D, Lox-hK-rasG12D-IRESHSV1-tk GFF cells were very sensitive to the GCV and their
growth was significantly inhibited at GCV concentration of
100 mg/ml. At the same time, cytotoxicity towards GCV
concentrations in LSL-hK-rasG12D-IRES-HSV1-tk GFFs and
wild-type GFF cells remained unaffected even at 100 mg/ml of
GCV.
PLOS ONE | www.plosone.org

Due to the lack of commercial antibody against mutant hK-ras,
we used PCR-restriction fragment length polymorphism (RFLP)
analysis to verify the existence of mutant hK-ras in the genome. In
both transgenic Lox-hK-rasG12D-IRES-HSV1-tk GFF and LSLhK-rasG12D-IRES-HSV1-tk GFFs cells infected by AdenovirusCre-GFP for 48 h, PCR-PFLP analysis indicated the presence of
186-bp band associated with mutant hK-ras in transgenic cells. On
the contrary, wild type GFF cells only had 156-bp cDNA fragment
(Figure 3E). The presence of dual 186-bp mutant band and 156-bp
cDNA band in transgenic Lox-hK-rasG12D-IRES-HSV1-tk GFF
cells suggested that two types of K-ras existed in two alleles, hKrasG12D and goat endogenous K-ras.
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Unexpectedly, no telomerase activities were observed in LoxhK-rasG12D-IRES-HSV1-tk GFF cells, wild type GFF cells and
LSL-hK-rasG12D-IRES-HSV1-TK GFF cells (Data not show
here). The Lox-hK-rasG12D-IRES-HSV1-tk GFF cells at passage
20 were still telomerase-negative. Similar observations that
activation of telomere maintenance strategies is not necessary an
obligated characteristic feature of tumorigenic cells were also
obtained in the literature [23].

Tumorigenesis in athymic nude mice
To further confirm the capability of tumorigenesis in vivo after
activating hK-rasG12D expression, both LSL-hK-rasG12D-IRESHSV1-tk and Lox-hK-rasG12D-IRES-HSV1-tk GFF cells were
introduced via s.c. transplantation into athymic nude mice. We
monitored tumor formation and tumor growth for 11 weeks post
cell injection (Figure 5A). Mice receiving LSL-hK-rasG12D-IRESHSV1-tk GFF cells did not exhibit any tumor growth during the
course of 11 weeks, while mice inoculated with Lox-hK-rasG12DIRES-HSV1-tk GFF cells resulted in palpable tumors within 2
weeks, with tumor formation incidence of 40% during 11 weeks
(2/5).
To further confirm the tumor mass, Positron Emission
Tomography (PET) was deployed to image the tumor mass that
developed in the mice using 2-deoxy-2-(18F)-fluoro-D-glucose
(18F-FDG) probe. 18F-FDG, as a glucose analog, was taken up by
high-glucose-consuming tumor cells, which yielded a higher
contrast associated with tumor mass in PET image. As shown in
Figure 5B, palpable mass exhibited enhanced 18F-FDG uptake in
the mice inoculated with Lox-hK-rasG12D-IRES-HSV1-tk GFF
cells when compared with the control group comprising the mice
inoculated with the non-activated transgenic cells.
In conclusion, after activating hK-rasG12D gene expression, hKrasG12D transgenic GFF cells were transformed into tumorgenesis
cells.

Figure 2. Results of screening PCR in two targeting GFF cells. A,
PCR was performed using primers V01 and V02. The wild type allele was
denoted by the 3 kb fragment and the recombined LSL-hK-rasG12DIRES-HSV1-tk allele was denoted by 6 kb fragment. B, PCR was
performed using the primers V01 and V03. The wild type allele could
not be denoted by any fragment using these pair of primers, and only
the recombined LSL-hK-rasG12D-IRES-HSV1-tk allele was denoted by
5.7 kb fragment. The fragments in lane1 and lane2 were purified from
the gel and then were subject to sequencing. C, PCR was performed
using primers V04 and V05. The wild allele type was denoted by the
8 kb fragment, and the recombined LSL-hK-rasG12D-IRES-HSV1-tk allele
was denoted by 10 kb fragment. WT: wild-type GFF cells. No. 1 and
No. 2: Targeting cells. Position and orientation of PCR primers used for
the analysis are depicted.
doi:10.1371/journal.pone.0090059.g002

Phenotyping transgenic Lox-hK-rasG12D-IRES-HSV1-tk GFF
cells
The morphology of Lox-hK-rasG12D-IRES-HSV1-tk GFF cells
was quite different from the appearance of classic fibroblast
(Figure 4A). It was observed that LSL-hK-rasG12D-IRES-HSV1-tk
GFF cells could grow very quickly at an early passage, but began
to grow very slowly after passage 5 and became senescent [22].
Senescent LSL-hK-rasG12D-IRES-HSV1-tk GFF cells were unable
to divide and exhibited an enlarged and flattened morphology
(Figure 4A). On the contrary, Lox-hK-rasG12D-IRES-HSV1-tk
GFF cells did not undergo the senescent stage and kept fast
proliferation. As shown in Figure 4B, transgenic human KrasG12D-expressing fibroblasts featured an enhanced proliferative
property. Lox-hK-rasG12D-IRES-HSV1-tk GFF cells had a
doubling time of 24 hours, obtained from the growth curve and
calculated by the formula of log (final number of collected cells/
initial number of seeded cells)/log2.
Lox-hK-rasG12D-IRES-HSV1-tk GFF cells were further characterized using colony formation assay to determine the consequences of hK-rasG12D expression. We observed that the
activation of hK-rasG12D expression enabled an anchorageindependent growth. Whereas the wild type GFF cells and LSLhK-rasG12D-IRES-HSV1-tk GFF cells did not form any colonies in
methylcellulose, Lox-hK-rasG12D-IRES-HSV1-tk GFF cells
showed spherical colony formation with 2 weeks of seeding, and
expanded colonies were observed within 3 weeks (Figure 4D). The
anchorage-independent growth behavior associated with the LoxhK-rasG12D-IRES-HSV1-tk GFF cells suggested the occurrence of
neoplastic transformation after activating K-ras expression and
indicated that Lox-hK-rasG12D-IRES-HSV1-tk GFF cells are
transformed cells.

PLOS ONE | www.plosone.org

Discussion
In this work, we developed transgenic goat cells with hK-ras and
HSV1-tk genes using primary GFF cells. Comparing with similar
works on mouse model development [12–15], we found wild-type
GFF cells are quite different from mouse embryonic fibroblast
(MEF) cells. Wild-type MEF cells senesced after 5–10 passages,
while wild-type GFF cells grew very fast and kept proliferating
after 20 passages. Once wild-type GFF cells were turned into
transgenic LSL-hK-rasG12D-IRES-HSV1-tk cells, they began to
grow slowly after 5 passages and became senescent, while there
was not much difference in growth rate between wild-type MEF
and transgenic MEF cells. After hK-ras was activated in transgenic
GFF cells, the activated cells started to grow aggressively — faster
than the wild-type GFF and became tumor genesis (Figure 4). A
relatively faster growth rate is a characteristic feature for wild-type
GFF cells.
Our initial experiments based on the design of the vector
construction targeted exon 0 locus of goat endogenous K-ras were
failed. Based on the genome data [24,25], goat K-ras promoter
region is very rich in G and C, lacks TATA and CCAAT boxes,
and contains sequence similarities with other house-keeping genes,
such as dihydrofolate reductase (DHFR) and epidermal growth
factor (EGF) receptor genes. The promoter of the c-K-ras gene
consists of multiple elements, and initiation of transcription occurs
at multiple sites. Sequences overlapping with the 59 end
untranslated exon; therefore, downstream from the major
transcription initiation sites is important (although not sufficient)
for transcription. Considering that any mismatch induced by
5
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Figure 3. Activating hK-ras expression in LSL-hK-rasG12D-IRES-HSV1-tk GFF cells by Adenovirus -Cre-GFP. A. Morphology of GFP
positive cells 48 hr after infection with adenovirus-Cre-GFP. Phase contrast (Left panel) and florescent micrographs (Right panel) were shown at 1006
magnification. B. Efficient excision of the LSL cassette in the cell culture. PCR analysis of genomic DNA prepared from the different GFF cells. The wild
type allele was devoted the 279 bp fragment. The LSL-hKrasG12D-IRES-HSV1-TK allele was devoted 2.5 kb fragment. The Lox- hKrasG12D-IRES-HSV1-TK
allele was devoted the 320 bp fragment. 1: Lox- hK-rasG12D-IRES-HSV1-tk GFF cells, 2: LSL-hK-rasG12D-IRES-HSV1-tk GFF cells, 3: wild-type GFF cells. C.
mRNA of HSV1-tk in GFF cells. Marker: 100 bp ladder, 1: LSL-hK-rasG12D-IRES-HSV1-tk GFF was infected with Adenovirus-Cre-GFP 48 h. 2: LSL-hKrasG12D-IRES-HSV1-tk GFF cells. 3: Lox- hK-rasG12D-IRES-HSV1-tk GFF cells, 4: wild-type GFF cells, N: negative control (H2O as template). D. Dependence
of ganciclovir concentrations against GFF cell viability using MTT assays. The results were expressed as the percentage of living cells in treated
conditions at various concentrations of ganciclovir with respect to ganciclovir-free cultures. E. Specific reduction of mutant hK-ras transcripts in GFF
cells. BstNI digestion cuts the WT K-ras allele to produce a 156-bp DNA fragment, whereas the mutant hK-ras allele remains uncut to produce a 186bp DNA fragment. 1: wild-type GFF cells, 2: LSL-hK-rasG12D-IRES-HSV1-tk GFF cells, 3: Lox- hK-rasG12D-IRES-HSV1-tk GFF cells, 4: LSL-hK-rasG12D-IRESHSV1-tk 48 h post infection.
doi:10.1371/journal.pone.0090059.g003

homologous recombination of exon 0 would greatly impair the
promoter’s activity of the upstream elements, we changed our
design to target exon 1.
Among 56 drug-resistant colonies of GFFs, we were able to
obtain two colonies with the right homologous recombination, i.e.,
with a target enrichment efficiency (TRE) of 3%. Compared to the
efficiencies of 1–2% [26,27] in murine embryonic stem cells, our
TRE is relatively high but similar to other reports for homologous
recombination in sheep, goats, and cattle [28]. The use of a
promoter-less gene-targeting vector could further enhance the
target efficiency.
Based on the structure of the vector, the ratio of expression level
between the endogenous goat K-ras and mutated hK-ras would be
1:1. The observation of cell transformation indicated that the
mutated hK-ras gene product replaced the function of endogenous
goat K-ras gene and remained in an active GTP-bound state; thus,
contributed to the uncontrolled cellular proliferation for tumor
PLOS ONE | www.plosone.org

formation. K-ras is a highly conservative gene, and a blast analysis
from NCBI revealed 95% sequence similarity between human Kras and goat K-ras. Since the mutated region in K-ras is identical
in mouse, goat, and human, we expected that the outcome would
be similar if we mutated the goat K-ras gene.
It is also interesting to notice that a single mutation of K-ras can
initiate the transformation of a fibroblast cell into a tumorigenic
cell without the need of a co-factor. Similar results were observed
in murine and human cell lines [29,30]. Although it is widely
accepted that fibroblasts play a prominent role in the progression,
growth, and spread of cancers, their functions are normally
achieved through microenvironment niches, where their production of growth factors, chemokines, and extracellular matrix
facilitates the angiogenic recruitment of endothelial cells and
pericytes. The transformation of fibroblast to tumor cells via hKras mutation reported herein supports the discussions of expanded
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Figure 4. Phenotypic changes of transformed cells. A. Morphological properties of transgenic GFF cells. Phase contrast micrographs were
shown at 2006magnification. B. Proliferation curves of wild-type GFF cells, LSL-hK-rasG12D-IRES-HSV1-tk and Lox-hK-rasG12D-IRES-HSV1-tk GFF cells to
indicate enhanced proliferation. 2000 cells per well were seeded in the 96-well plate and incubated for indicated time. The cells were determined by
MTT assay. C. Quantification of colony formation between LSL-hK-rasG12D-IRES-HSV1-tk and Lox-hK-rasG12D-IRES-HSV1-tk GFF cells. 1, LSL-hK-rasG12DIRES-HSV1-tk GFF cells. 2, Lox-hK-rasG12D-IRES-HSV1-tk GFF cells. Columns, average of five random fields per dish from two dishes; bar, standard
deviation (*, p,0.01; chi-square test). D. The anchorage-independent growth of transgenic cells. Cells were suspended in methylcellulose to evaluate
anchorage-independent growth potential over 21 days. Bright field micrographs were shown at 1006 magnification (2 weeks) and 2006
magnification (3 weeks).
doi:10.1371/journal.pone.0090059.g004

role of fibroblast in cancer as direct tumor genesis instead of the
current view of its function as an influence factor [31–33].
As the first experiment to generate xenograft mice using goat
cancer cells, the tumor growth in the nude mice was relatively slow
compared to that using human cancer cells (Figure 5). This could
be due to the nature of goat cells and the presence of normal
endogenous K-ras (50% theoretically) in addition to the mutated
human K-ras gene in the transgenic cells.
The integration of a nuclear imaging reporter gene (HSV1-tk in
this case) enables imaging and quantifying mutated K-ras gene
product in vivo as well as the subsequent phenotypes. Such
capability is very important to facilitate generating a large-animal

PLOS ONE | www.plosone.org

model of cancer. Rather than relying purely on the appearance of
disease phenotype, which may take a much longer time in large
animals (or may not happen at all), one could follow the stages of
model development by assessing the oncogene product levels in vivo
and adjusting the strategies and approaches at an early stage based
on the imaging results. In addition, the development of cloned
transgenic large animals and the ability to evaluate pharmacologic
parameters through imaging would significantly lower the expense
and the numbers of animals needed for any pharmacologic studies.
Using the transgenic cells as donor cells, five K-ras transgenic
goat kids have been produced at USU using the somatic cell
nuclear transfer technique. Tissue specific activation of K-ras and
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restriction endonuclease. Lane 1: plasmid pKO2.1-long arm;
Lane 2: pKO2.1-long arm/AgeI; Lane 3: pKO2.1-long arm/
BglII; Lane 4: pKO2.1-long arm/AflII; Lane 5: pKO2.1-long
arm/NotI. Figure S3. Agarose gel electrophoresis of inserted PCR
fragments and linearized vector. Lane 1: splicing acceptor
(400 bp); Lane 2: K-rasG12D-iresTK (2 kb); Lane 3: SA-KrasG12D-iresTK (2.4 kb); Lane 4: LoxP-neomycin-stop-LoxP
(2.7 kb); Lane 5: 59-homologous arm (2 kb); Lane 6: 39homologous arm (7 kb); Lane7: linearized pKO2.1-long arm
(10 kb). Figure S4. Agarose gel electrophoresis of In-fusion cloning
reaction. Lane 1: linearized vector (10 kb); Lane 2: 59-homologous
arm (2 kb); Lane 3: LSL (2.7 kb); Lane 4: SA-K-rasG12D-iresTK
(2.4 kb); Lane 5: linearized recombinant vector (17 kb). Figure S5.
Identification of pko2.1-LSK-K-rasG12D-iresTK vector digested
with restriction enzymes and confirmation of three positive
colonies. Figure S6. Depicting the design of screening primers.
V01 and V02, V01 and V03 as the screening primer pairs could
detect the homologous recombination taken place in the short
arm. V04 and V05 as the screening primer pair could detect the
homologous recombination taken place in the long arm. Figure
S7. Depicting primer design for confirming the excision of LoxP
embedded neo gene. V06 and V07 were designed outside of the
two LoxP sites and would lead to amplifying different length of
fragments from two different alleles.
(ZIP)

Figure 5. Tumor formation in mice inoculated with Lox-hKrasG12D-IRES-HSV1-tk GFF cells. A. Tumor growth curves of mice
bearing Lox-hK-rasG12D-IRES-HSV1-tk GFF cells. Inset. Dissected tumor
masses from the 5 mice. B. Coronal microPET images of nude mouse
inoculated with Lox-hK-rasG12D-IRES-HSV1-tk GFF cells after injection of
18
F-FDG. Red arrow indicates palpable tumor mass. Mouse inoculated
with LSL-hK-rasG12D-IRES-HSV1-tk GFF cells was used as a control.
doi:10.1371/journal.pone.0090059.g005

HSV1-tk genes will be carried out once the goats are 6 months to a
year old using Cre recombinant adenovirus. Depending on the
delivery site of Cre recombinant adenovirus, the transgenic goats
could be potential models for many types of cancer models,
ranging from lung cancer to kidney cancer.
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